MPS Code: 0195/2021
Venous thromboembolism (VTE) is the third most common cardiovascular disease after myocardial infarction and stroke. The goal of this learning activity is to provide pharmacists with a comprehensive review on the role of non-vitamin K antagonist oral anticoagulants (NOACs) in the management of VTE.
Upon completing this module, participants will have a better understanding of the following:
● Epidemiology and burden of disease
● Anticoagulant therapy
● The efficacy and safety profile of NOACs in the acute and extended treatment of VTE
Who should participate:
Please read thoroughly & understand the module before attempting the assessment questions.
Terms & Conditions:
■ Participants must obtain a minimum score of 7/10 (70%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points.
The modules/articles are best viewed with:
Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards-compliant browser may be required to view the modules.